Spero Therapeutics (SPRO) FCF Margin Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 10,029.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 723.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,409.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,066.00 |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | 1.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.19 Mn |
| Dec 31, 2025 | -15,153.00 |
| Sep 30, 2025 | 36,785.00 |
| Jun 30, 2025 | 103,100.00 |
| Mar 31, 2025 | 129,596.00 |
| Dec 31, 2024 | 9,951.00 |
| Sep 30, 2024 | 2.03 Mn |
| Jun 30, 2024 | 46,912.00 |
| Mar 31, 2024 | 27,612.00 |
| Sep 30, 2023 | 6.34 Mn |
| Jun 30, 2023 | 75,894.00 |
| Mar 31, 2023 | -438,755.00 |
| Dec 31, 2022 | 277,896.00 |
| Sep 30, 2022 | 16,069.00 |
| Jun 30, 2022 | 1.70 Mn |
| Mar 31, 2022 | -122,150.00 |
| Dec 31, 2021 | 62,344.00 |
| Sep 30, 2021 | 13,856.00 |
| Jun 30, 2021 | 107,965.00 |
| Sep 30, 2020 | -5.43 Mn |
| Jun 30, 2020 | 212,262.00 |
| Mar 31, 2020 | 360,887.00 |
| Dec 31, 2019 | -1.71 Mn |